FIELD: medicine.
SUBSTANCE: offered method provides introduction to mammal of lymphocyte conditioned medium containing "untrained" T-cells cultivated with CD3/CD28 antibodies covered granules, in combination with antigen. Method can be used in medicine.
EFFECT: allows for enhanced patient's immune system response to vaccine or another immunotherapeutic agent.
10 cl, 37 dwg, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IMMUNE THERAPY OF CHRONIC VIRAL HEPATITIS C | 2016 |
|
RU2637631C2 |
CELL PRODUCT FOR LOADING AND ACTIVATION OF HUMAN DENDRITE CELLS | 2019 |
|
RU2714208C1 |
DENDRITIC CELL GENERATION FROM MONOCYTIC DENDRITIC CELL PRE-CURSORS BY MEANS OF GM-CSF IN ABSENCE OF ADDITIONAL CYTOKINES | 2004 |
|
RU2364625C2 |
CO-DIFFERENTIATION OF MONOCYTES FROM ALLOGENEIC DONORS | 2013 |
|
RU2668816C2 |
METHOD OF INDUCING CYTOTOXIC ANTI-TUMOUR IMMUNE RESPONSE in vitro WITH USING DENDRITIC CELLS, TRANSFECTED BY RNA TUMOUR CELLS, TO NON-SMALL CELL LUNG CANCER | 2015 |
|
RU2578008C1 |
COMBINED CELL TRANSPLANT BASED ON LYMPHOKINE-ACTIVATED KILLERS AND DENDRITE CELLS, METHOD FOR PRODUCTION THEREOF AND METHOD FOR TREATMENT AND PROPHYLAXIS OF MALIGNANT, INFECTIVE DISEASES AND IMMUNODEFICIENT CONDITIONS | 2006 |
|
RU2309753C1 |
METHOD OF GENERATING CYTOTOXIC CELLS WITH ACTIVITY AGAINST NON-SMALL CELL LUNG CANCER CELLS | 2014 |
|
RU2577992C2 |
IMMUNOTHERAPY OF BREAST CANCER USING ANTIGEN-ACTIVATED DENDRITIC CELLS | 2016 |
|
RU2645464C1 |
METHOD FOR STIMULATING PRESENTING ACTIVITY OF DENDRITIC CELLS | 2019 |
|
RU2728592C1 |
AUTOLOGOUS VACCINE FOR ONCOTHERAPY AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2392946C2 |
Authors
Dates
2008-12-20—Published
2004-02-20—Filed